Evidence map›Paper›PMID 26498119›Full record

Observational studyPediatric nephrology (Berlin, Germany)2016

Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.

David T Selewski, Ashton Chen, Ibrahim F Shatat, Priya Pais, Larry A Greenbaum, Pavel Geier, Raoul D Nelson, Stefan G Kiessling, Patrick D Brophy, Alejandro Quiroga and 6 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Pediatric nephrology (Berlin, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Dietary intakes of children with nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2021
    Article
  9. Podocytopathies.Nature reviews. Disease primers · 2020
    Review
  10. Bone Health in Glomerular Kidney Disease.Current osteoporosis reports · 2019
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 4 countries.

David T SelewskiDivision of Nephrology, Department of Pediatrics and Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA. dselewsk@med.umich.edu.
Ashton ChenDepartment of Pediatrics, Section of Pediatric Nephrology, Wake Forest Baptist Health, Winston-Salem, NC, USA.
Ibrahim F ShatatDivision of Pediatric Nephrology and Hypertension, Sidra Medical and Research Center, Doha, Qatar.
Priya PaisDepartment of Pediatric Nephrology, St. John's Medical College Hospital, St John's National Academy of Health Sciences, Bangalore, India.
Larry A GreenbaumEmory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
Pavel GeierDivision of Nephrology, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.
Raoul D NelsonDivision of Nephrology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Stefan G KiesslingDepartment of Pediatrics, University of Kentucky, Lexington, KY, USA.
Patrick D BrophyStead Family Department of Pediatrics, Division of Nephrology, University of Iowa, Iowa City, IA, USA.
Alejandro QuirogaDeVos Children's Hospital, Grand Rapids, MI, USA.
Michael E SeifertDivision of Pediatric Nephrology, Department of Pediatrics, Washington University at St. Louis, St. Louis, MO, USA.
Caroline E StraatmannDepartment of Pediatrics, Louisiana State University and Children's Hospital, New Orleans, LA, USA.
John D MahanNationwide Children's Hospital, The Ohio State University, College of Medicine, Columbus, OH, USA.
Maria E FerrisPediatric Nephrology, UNC Kidney Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jonathan P TroostDivision of Nephrology, Department of Pediatrics and Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA.
Debbie S GipsonDivision of Nephrology, Department of Pediatrics and Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA.
University of Michigan–Ann Arbor · USAtrium Health Wake Forest Baptist · USChildren's Healthcare of Atlanta · USChildren's Hospital of Eastern Ontario · CAC. S. Mott Children's Hospital · USHelen DeVos Children's Hospital · USLouisiana State University · USMedical University of South Carolina · USNationwide Children's Hospital · USSt.John's Medical College Hospital · INUniversity of Iowa · USUniversity of Kentucky · USUniversity of North Carolina at Chapel Hill · USUniversity of Utah · USWashington University in St. Louis · US

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
NCATS NIH HHS KL2 TR000450NCATS NIH HHS UL1 TR000448NIDDK NIH HHS L40 DK099748
6 · The paper itself

Abstract

backgroundCross-sectional studies of children with prevalent nephrotic syndrome (NS) have shown 25-vitamin D (25(OH)D) deficiency rates of 20-100 %. Information on 25(OH)D status in incident patients or following remission is limited. This study aimed to assess 25(OH)D status of incident idiopathic NS children at presentation and longitudinally with short-term observation.

methodsMulticenter longitudinal study of children (2-18 years old) from 14 centers across the Midwest Pediatric Nephrology Consortium with incident idiopathic NS. 25(OH)D levels were assessed at diagnosis and 3 months later.

resultsSixty-one children, median age 5 (3, 11) years, completed baseline visit and 51 completed second visit labs. All 61 (100 %) had 25(OH)D < 20 ng/ml at diagnosis. Twenty-seven (53 %) had 25(OH)D < 20 ng/ml at follow-up. Fourteen (28 %) children were steroid resistant. Univariate analysis showed that children prescribed vitamin D supplements were less likely to have 25(OH)D deficiency at follow-up (OR 0.2, 95 % CI 0.04, 0.6). Steroid response, age, and season did not predict 25(OH)D deficiency. Multivariable linear regression modeling showed higher 25(OH)D levels at follow-up by 13.2 ng/ml (SE 4.6, p < 0.01) in children supplemented with vitamin D.

conclusionsIn this incident idiopathic NS cohort, all children at diagnosis had 25(OH)D deficiency and the majority continued to have a deficiency at 2-4 months. Supplemental vitamin D decreased the odds of 25(OH)D deficiency at follow-up, supporting a role for supplementation in incident NS.

Indexed as

AdolescentBiomarkersChildChild, PreschoolDietary SupplementsFemaleHumansIncidenceLinear ModelsLogistic ModelsLongitudinal StudiesMaleMidwestern United StatesMultivariate AnalysisNephrotic SyndromeOdds Ratio1,25-dihydroxyvitamin D25-hydroxyvitamin DBiomarkersParathyroid HormonePTH protein, humanVitamin D25(OH)D deficiencyChildrenNephrotic syndromePediatricVitamin D

Identifiers

PMID26498119
PMCPMC4758900
OpenAlexW2174837954

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.